Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.

[1]  Elie A Akl,et al.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. , 2012, Chest.

[2]  P. Lindqvist.  On the evolutionary advantage of coagulation factor V Leiden (FVL). , 2015, Current medicinal chemistry.

[3]  M. Monreal,et al.  Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy. , 2014, European journal of internal medicine.

[4]  G. Piazza.  Thrombophilia testing, recurrent thrombosis, and women's health. , 2014, Circulation.

[5]  L. Howard,et al.  NICE guideline: management of venous thromboembolic diseases and role of thrombophilia testing , 2012, Thorax.

[6]  F. Rosendaal,et al.  Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. , 2012, Blood.

[7]  D. Jiménez,et al.  Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs , 2012, Journal of thrombosis and haemostasis : JTH.

[8]  Jason C. Fish,et al.  Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[9]  Paolo Prandoni,et al.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[10]  Gordon H. Guyatt,et al.  Evidence-Based Management of Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis , 2011 .

[11]  Lisa Moores,et al.  Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. , 2010, Archives of internal medicine.

[12]  A. Shorr,et al.  The validation and reproducibility of the pulmonary embolism severity index , 2010, Journal of thrombosis and haemostasis : JTH.

[13]  Jodi B Segal,et al.  Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. , 2009, JAMA.

[14]  M. Monreal,et al.  Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. , 2009, Thrombosis research.

[15]  F. Rosendaal,et al.  Mechanisms of the Factor V Leiden Paradox , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[16]  G. Guyatt,et al.  Physicians Evidence-Based Clinical Practice Development : American College of Chest Thrombolytic Therapy Guideline Methodology for Antithrombotic and , 2008 .

[17]  M. Khamashta,et al.  A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. , 2007, Arthritis and rheumatism.

[18]  Paolo Prandoni,et al.  The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. , 2007, Haematologica.

[19]  K. Kurnik,et al.  Effects of the factor V G1691A mutation and the factor II G20210A variant on the clinical expression of severe hemophilia A in children--results of a multicenter studys. , 2007, Haematologica.

[20]  Giancarlo Agnelli,et al.  Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[21]  M. Monreal,et al.  The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients. , 2003, Journal of vascular surgery.

[22]  J. Douketis,et al.  A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. , 2003, The New England journal of medicine.

[23]  T. Baglin,et al.  Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study , 2003, The Lancet.

[24]  F. Bernardi,et al.  Predictive Value of D‐Dimer Test for Recurrent Venous Thromboembolism After Anticoagulation Withdrawal in Subjects With a Previous Idiopathic Event and in Carriers of Congenital Thrombophilia , 2003, Circulation.

[25]  A. George,et al.  Factor V Leiden Protects Against Blood Loss and Transfusion After Cardiac Surgery , 2003, Circulation.

[26]  P. Prandoni,et al.  Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. , 2002, Blood.

[27]  M. Baiget,et al.  The prothrombin 20210A allele influences clinical manifestations of hemophilia A in patients with intron 22 inversion and without inhibitors. , 2002, Haematologica.

[28]  M. Margaglione,et al.  Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. , 2000 .

[29]  B. Ritchie,et al.  Effect of the Factor V Leiden Mutation on the Clinical Expression of Severe Hemophilia A , 2000, Thrombosis and Haemostasis.

[30]  J. M. Rodriguez,et al.  Comparison of the Risk of Pulmonary Embolism and Deep Vein Thrombosis in the Presence of Factor V Leiden or Prothrombin G20210A , 2000, Thrombosis and Haemostasis.

[31]  A. Moulton,et al.  Aprotinin, cardiac surgery, and factor V Leiden , 1997, Transfusion.

[32]  P. Mannucci,et al.  Low Prevalence of Factor V:Q506 in 41 Patients with Isolated Pulmonary Embolism , 1997, Thrombosis and Haemostasis.

[33]  J. Griffin,et al.  A single genetic origin for a common Caucasian risk factor for venous thrombosis. , 1997, Blood.

[34]  S. Lopaciuk,et al.  Prevalence of factor V Leiden mutation in various populations , 1997, Genetic epidemiology.

[35]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[36]  R. Hull,et al.  Antithrombotic therapy for venous thromboembolic disease. , 1986, Chest.